Co-Founder at Ariya Bio (to be incorporated) developing genome-engineered red cells to cure blood disorders. Molecular Health Science graduate from ETH Zürich.
Blutarmut gehört weltweit zu den häufigsten Erbkrankheiten. Die ETH-Forscherin Mandy Boontanrart hat nun einen vielversprechenden Ansatz für deren Behandlung entdeckt. 🧬✂️ #CRISPRCas#Genschere#Blutarmut @Innosuisse @snf_ch
Erfahren Sie mehr:👇 https://t.co/9JyHtKU8VF
#CRISPR#globinopathy therapies target fetal globin. But delta globin is closer to adult globin *and* is expressed at low levels throughout life.
@ETH_Entprenship
Fellow Mandy Boontanrart developed #geneediting "fix" for delta promoter! Finally out @eLife https://t.co/grwmgwe5Gc
Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease
-- my interview for @GENbio with Mandy Boontanrart @ETH_en on her clever strategy to switch up delta globin to treat #sicklecelldisease#CRISPR, just published @eLife
https://t.co/0EvVndmDA4
Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease
-- my interview for @GENbio with Mandy Boontanrart @ETH_en on her clever strategy to switch up delta globin to treat #sicklecelldisease#CRISPR, just published @eLife
https://t.co/0EvVndmDA4